Avalyn Pharma
The Director, Clinical Development at Avalyn will provide medical oversight and scientific leadership for IPF/ILD clinical trials, guiding protocol design, safety monitoring, data interpretation, and regulatory interactions. This role collaborates cross‑functionally with operations, biostatistics, regulatory affairs, and external partners to ensure trial integrity and patient safety throughout the drug development lifecycle.
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company's approach focuses on delivering inhaled formulations of established medicines directly to lung tissue to potentially enhance efficacy and reduce systemic side effects. Its pipeline includes two clinical-stage programs, AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib), as well as a preclinical program, AP03, a fixed-dose combination of both agents.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Avalyn Pharma.
Right around the average for this role
Avalyn Pharma
Aug 5, 2025
Sr Director, Clinical Sciences
Tarsus Pharmaceuticals
Senior Clinical Scientist
Arcus Biosciences
Associate Medical Director, Clinical Development
Tonix Pharmaceuticals
Associate Director Biostatistics United States
alnylam
Clinical Research Director
Sanofi
Associate Director, Clinical Scientist
Madrigal Pharmaceuticals